CollPlant (CLGN) Biotechnologies announced the expansion of its distribution footprint into North America through a new partnership with a U.S.-based logistics center. Scheduled to become operational this quarter, the logistics hub will provide full cGMP-compliant storage and distribution services and will serve as a clinical supply depot. This expansion will support CollPlant’s growing customer base for its rhCollagen and BioInk product lines in both the U.S. and Canada. The new U.S. logistics center features state-of-the-art infrastructure, including cGMP-controlled storage environments, a cloud-based temperature monitoring system, advanced emergency back-up capabilities, AI-powered security, and remote inventory management. These capabilities ensure reliable, efficient, and secure distribution to meet the quality and regulatory expectations of CollPlant’s partners and customers.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLGN:
- CollPlant’s BioInk Outperforms Matrigel in Technion Study
- CollPlant’s Collink.3D shows strong performance vs. Matrigel in study
- CollPlant and Mayo Clinic Unveil Humanized 3D Bioprinted Skin Model
- Morning News Wrap-Up: Tuesday’s Biggest Stock Market Stories!
- Why Is Collplant Stock (CLGN) Down 25% Today?
